Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in APRE — Aprea Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in APRE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$28,021
+$18,089 QoQ
Shares Held
34,939
+168.4% QoQ
Ownership
0.277%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 28 holders
Holding Since
Mar 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APRE Over Time

Shares Held

Position Value (USD)

Derivatives in APRE

reported options exposure · as of Dec 31, 2023
CallValue
$490,210
CallShares
104,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. APRE ranks #309 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in APRE

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $28,021 34,939
2026-03-31 $9,932 13,018
2024-06-30 $41,184 10,119
2023-12-31 $490,210 104,300
2023-09-30 $434,618 104,300
2023-06-30 $328,545 104,300
2023-03-31 $489,732 110,300
2022-12-31 $47,862 144,600
2022-12-31 $4,423 13,365
2022-09-30 $93,990 144,600
2022-09-30 $11,480 17,662
2022-06-30 $46,467 61,957
2022-06-30 $97,275 129,700
2022-03-31 $18,972 10,200
2022-03-31 $207,146 111,369
2022-03-31 $232,872 125,200
2021-12-31 $98,154 34,200
2021-12-31 $188,814 65,789
2021-12-31 $67,158 23,400
2021-09-30 $682,185 133,500
2021-09-30 $1,020,226 199,653
2021-06-30 $347,456 71,200
2021-06-30 $209,352 42,900
2021-06-30 $356,537 73,061
2021-03-31 $107,610 21,100
2021-03-31 $102,510 20,100